13F

Stock

Neurocrine Biosciences Inc

NBIX · held by 14 managers

Reported value

$63.6M

Holders

14

+2 new · −0 exited

Holders’ est. mark

$6.4M

Price effect on 11 books still in the name

Largest holder

$34.1M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC271.4K$34.1M$3.02MAdded$12M
PKO BP BANKOWY Universal Pension Society JSC138.8K$17.4M$2.09MAdded$2.09M
DANSKE BANK A/S44.7K$5.62M$657.1KAdded$804.1K
Swiss Life Asset Management Ltd13.5K$1.69M$203.3KAdded$37.9K
OP Asset Management Ltd11.5K$1.45M$160.4KAdded$272.1K
ONTARIO TEACHERS PENSION PLAN BOARD10.1K$1.27M$152.3KCut−$432.5K
Sanctuary Advisors, LLC6.61K$831.1K$59.8KAdded$393.6K
VIRTUS ADVISERS, LLC2.58K$324.8K$39KAdded$39K
Essential Partners LLC2.58K$324.3KHeld
Savant Capital, LLC2.41K$302.9KNew
Leonteq Securities AG1.06K$133.5K$15.8KCut−$4.98K
ELEVATION POINT WEALTH PARTNERS, LLC768$96.5KNew
Aventura Private Wealth, LLC39$4.9K$589Added$589
Prestige Wealth Management Group LLC25$3.14K$378Cut−$1.72K

Positions as of Q2 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.